News · The Korea Economic Daily·

Vorono rises 7%+ as European trial change approval for lead drug candidate adds countries

Predicted impact: Medium

European trial approval for a lead drug candidate adds countries; meaningful pipeline progress.

Comments

Sign in to comment

No comments yet. Start the conversation.

Comments are people's own views. Nothing here is financial advice.